The In-Q Knowledge Center for FDA Compliance is a new platform designed to streamline compliance for U.S. Food and Drug Administration (FDA)-regulated manufacturers and importers.

This article focuses on one of the three branches within the newly created U.S. Food and Drug Administration (FDA) Human Foods Program—the Office of Food Chemical Safety, Dietary Supplements, and Innovation—and its potential impact on food packaging.

Bimbo Bakeries’ response letter to an FDA warning letter about intentionally adding sesame to its products and falsely listing sesame as an ingredient on products has been revealed by consumer protection groups. In short, the company defended its practice. 

U.S. Senators Edward Markey and Cory Booker recently wrote a letter to the U.S. Food and Drug Administration (FDA) urging the agency to revoke its authorization for phthalates in food contact materials, arguing that the chemicals are proven to be toxic. 

The U.S. Food and Drug Administration (FDA), the U.S. Environmental Protection Agency (EPA), and the U.S. Department of Agriculture (USDA) have released an online tool to help biotechnology companies better understand the regulatory requirements for genetically modified organisms (GMOs).

On October 1—the first effective date of the U.S. Food and Drug Administration’s Human Foods Program (FDA’s HFP), as the agency begins implementing its reorganized structure—the HFP introduced a streamlined approach for processing complaints from the public about foods and dietary supplements.

In February 2024, FDA clarified the regulatory pathway for human and animal foods produced from genome-edited plants in a final guidance titled Foods Derived from Plants Produced Using Genome Editing: Guidance for Industry.

Small and midsized businesses striving for full compliance with the Preventive Controls for Human Food Rule (PCHF Rule) average $22,000 in upfront costs and $8,000 in every subsequent year, one study suggests.

In a September 25 public meeting and supplementary document, the U.S. Food and Drug Administration (FDA) outlined its developing enhanced, systematic process for the post-market assessment of chemicals in food. The proposed process is open for public comment until December 6.

The U.S. Food and Drug Administration (FDA) has updated the Mycotoxins in Domestic and Imported Human Foods Compliance Program to include T-2/HT-2 toxins and zearalenone, and to reflect the use of a new multi-mycotoxin method for analysis in human foods.